42
total announcements
543427.BO · 15 min delayed
Medplus Health Services Ltd
Medplus Health Services Ltd has announced earnings calls for the quarter and half-year ended September 30, 2026, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a disclosure of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 from Lone Furrow Investments Pvt Ltd on October 07, 2026.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a disclosure from Agilemed Investments Pvt Ltd, a promoter, regarding encumbrance under SEBI (SAST) Regulations, 2011.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Lone Furrow Investments Pvt Ltd, indicating a potential change in control or significant stake acquisition.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Agilemed Investments Pvt Ltd, indicating a potential change in shareholding.
Medplus Health Services Ltd
Medplus Health Services Ltd has issued a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026, certifying that the details of securities dematerialized/rematerialized have been furnished to all the stock exchanges where the company's shares are listed.
Medplus Health Services Ltd
Medplus Health Services Ltd has announced that its material subsidiary, Optival Health Solutions Private Limited, has had its credit ratings reaffirmed by CareEdge Ratings Limited. The ratings for long-term bank facilities and short-term bank facilities are CARE A; Stable and CARE A1 respectively.
Medplus Health Services Ltd
Medplus Health Services Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter and half-year ended September 30, 2026. The board meeting to consider and approve these results is scheduled for October 27, 2026.
Medplus Health Services Ltd
Medplus Health Services Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 27/10/2026 to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026.
Medplus Health Services Ltd
Medplus Health Services Ltd has disclosed reasons for encumbrance by its promoters under SEBI (SAST) Regulations, 2011. Agilemed Investments Private Limited, Lone Furrow Investments Private Limited, and Madhukar Reddy Gangadi have pledged shares with various entities.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Agilemed Investments Pvt Ltd regarding the creation of a pledge of 5,00,000 shares by Madhukar Reddy Gangadi, a promoter of the company.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Catalyst Trusteeship Ltd.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from ICICI Prudential Mutual Fund.
Medplus Health Services Ltd
Medplus Health Services Ltd has announced the voting results and scrutinizer's report of its 20th Annual General Meeting (AGM) held on August 17, 2026, through video conferencing. The company has approved all six resolutions with the requisite majority.
Medplus Health Services Ltd
Medplus Health Services Ltd held its 20th Annual General Meeting on August 17, 2026, through video conferencing, with 134 members attending. The meeting was chaired by Gangadi Madhukar Reddy, Chairman & Managing Director and CEO, and the statutory auditors and secretarial auditors expressed unqualified opinions in their reports for the financial year 2025-2026.
Medplus Health Services Ltd
Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for drug licenses at stores in Karnataka, resulting in potential revenue loss of Rs 0.24 lacs, Rs 0.17 lacs, and Rs 0.23 lacs respectively.
Medplus Health Services Ltd
Medplus Health Services Ltd's subsidiary Optival Health Solutions Private Limited has received a two-day suspension order for a drug license for a store in Karnataka, resulting in a potential revenue loss of Rs 0.71 lacs.
Medplus Health Services Ltd
Medplus Health Services Ltd has received a rectification of disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 from Catalyst Trusteeship Ltd, correcting the date of acquisition of shares from June 24, 2026 to July 24, 2026.
Medplus Health Services Ltd
Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, received a five-day suspension order for a drug license of a store in Telangana due to a contravention under the Drugs and Cosmetics Act, 1940.
Medplus Health Services Ltd
Medplus Health Services Ltd has made a disclosure under SEBI (SAST) Regulations, 2011, regarding reasons for encumbrance by its promoter.